2025-11-10T09:49:13-08:00 2024-12-31 260735604 Mogg & Associates LLC 5601 S Broadway Ste 440 Littleton CO 80121 990 2024-01-01 825300929 FOXG1 Research Inc FOXG 5164415067 One Luckenbach Lane Sands Point NY 11050 Ryan Phillips CFO 2025-11-10 true true Bryan D Mogg P00237137 7209459100 2024 2025-03-06 01:10:19Z Ryan Phillips One Luckenbach Lane Sands Point NY 11050 11288365 false X WWW.FOXG1RESEARCH.ORG X 2018 NY Find a cure, find treatments, provide therapeutics, advocating for patients, and supporting families for FOXG1 Syndrome. 4 4 0 7 0 1667490 6564658 0 115839 46736 -3940 -3797 1779389 6607597 426600 1226351 0 162500 180000 65550 160060 160060 318324 2094732 972974 3661143 806415 2946454 2924279 5890175 0 2924279 5890175 Find a cure, find treatments, provide therapeutics, advocating for patients, and supporting families for FOXG1 Syndrome. false false 3293202 1226351 6564658 Fund research to find a cure. 3293202 true true false false false false false false false false false false false false false false true false false false false true false true false false false true false true false false false false false false false false true false false false false false false false false true 4 0 true 0 false false false false false false false 0 false false false false false false false X 4 4 false false false false false false false false false false false true false false false false false false NY The Organization 5164415067 One Luckenbach Lane Sands Point NY 11050 X Nicole Johnson Executive Director 40.00 0.00 180000 0 0 Bram van Den Bergh Treasurer 3.00 0.00 X X 0 0 0 Nasha Fitter CEO and Chair 7.00 0.00 X X 0 0 0 Ryan Phillips CFO 7.00 0.00 X X 0 0 0 Magdelena Labbe Secretary 3.00 0.00 X X 0 0 0 180000 1 false true false Kerem Consulting LLC One Luckenbach Lane Sands Point NY 11050 Chief Drug Dev Officer 350000 1 6564658 1675892 6564658 0 26304 26304 0 0 0 4688228 4667796 20432 20432 20432 0 0 9175 12972 -3797 -3797 0 6607597 42939 X 920000 920000 675 675 305676 305676 0 180000 180000 0 0 0 0 0 350004 350004 0 15700 15700 0 160060 160060 0 1494477 1494477 27604 27604 27110 27110 0 0 0 34957 34957 0 131336 131336 0 0 0 549 549 Bank Charges 11632 11632 Postage and Shipping 1090 1090 Printing and Publications 273 273 0 3661143 3293202 207881 160060 1130575 822474 287702 1963227 1650000 0 0 0 0 0 0 0 1506002 1454474 0 0 0 0 2924279 5890175 0 0 X 2924279 5815175 75000 2924279 5890175 2924279 5890175 2946454 19442 X false false false X 905722 2778717 994062 1667489 6564658 12910648 0 0 905722 2778717 994062 1667489 6564658 12910648 0 12910648 13 20237 16631 31223 26304 94408 0 0 13005056 0.99270 0.98970 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 6607597 6607597 6607597 3661143 3661143 3661143 true United Kingdom Research 305676 WireTransfer 1 false false false false false false Part I, Line 2 - Grantmakers Explanation For Monitoring Use of Funds Outside US The grantee must provide periodic (e.g., quarterly, semiannual, or annual) written reports detailing the use of grant funds and progress toward the grants objectives. Part I, Line 3f - Method of Accounting Accrual basis of accounting used. Part I, Line 3f - Investments and Expenditures $305,676 for research in the United Kingdom. X X X X X X false NY true University of Buffalo C533 Cooke Hall Buffalo NY 14260 161514621 501(c)(3) 920000 0 Research 1 0 false false false false false false false false false Nicole Johnson Executive Director 180000 180000 X 7 1675892 Comparable Sales false false false Form 990, Part VI, Section B, Line 11b All board members will receive a copy of the 990, there will be time for discussion, and then the board will vote to approve it. Form 990, Part VI, Section C, Line 19 No documents available to the public.